Established in 1935, Cipla stands for The Chemical, Industrial, Pharmaceutical Laboratories. Head Office is based in Mumbai, with plants based in Bangalore, Vikhroli, Patalganga, Kurkumbh, Goa, Baddhi.
Cipla is currently India’s second largest pharmaceutical Company in terms of sales and it produces a range of low-cost pharmaceutical ingredients (APIs), prescription drugs, OTC products, and formulations. Exports constitute approximately 50% of its sales and it markets products in more than 170 countries. Formulations accounted for 73% of Cipla’s exports in 2006 and APIs accounted for the remaining 27%.
About the Audit
The audit on Cipla Bangalore site was performed on 26 February – 1 March 2007. The Audit Report includes photographs and is 53 pages long, excluding appendices. Including appendices, the Report is 123 pages long.
The Audit Report provides information on the site facilities and covers the materials Anagrelide HCL Monohydrate, Amlodipine Besylate, Amlodipine Mesylate, Amlodipine Maleate, Alprazolam, Anastrozole, Bicalutamide, Cisplatin, Carboplatin, Capecitabine, Duloxetine HCL, Donepezil HCL, Didanosine, Etoposide, Flutamide, Felodipine, Granisetron Base, Granisetron HCL, Irinotecan HCL Trihydrate, Imatinib Mesylate, Lansoprazole, Lamotrigine, Leflunomide, Letrozole, Levofloxacin Hemihydrate, Losartan Potassium, Mebendazole IP/USP, Mebendazole Suspension Grade, Mebendazole Polymorph ‘C’, Mitoxantrone Hydrochloride, Omeprazole, Esomeprazole Magnesium Trihydrate, Esomeprazole Magnesium Dihydrate, Omeprazole Magnesium, Omeprazole Sodium, Ofloxacin, Oxcarbazepine, Oxaliplatin, Pantoprazole Sodium Sesquihydrate, Risperidone, Rabeprazole Sodium, Ribavirin, Riluzole, Selegiline HCL, Stavudine, Topiramate, Topotecan Hydrochloride, Vincristine Sulphate, Vinblastine Sulphate, Vinorelbine Tartrate, Zidovudine, along with a comprehensive review of their quality systems.